Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies

被引：2
|
作者：
Niscola, Pasquale [1 ]
Gianfelici, Valentina [1 ]
Catalano, Gianfranco [2 ]
Giovannini, Marco [1 ]
Mazzone, Carla [1 ]
Noguera, Nelida Ines [2 ,3 ]
de Fabritiis, Paolo [1 ,2 ]
机构：
[1] S Eugenio Hosp ASL Roma 2, Hematol Unit, I-00144 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy
[3] IRCCS, St Lucia Fdn, Neurooncoemtol Units, I-00143 Rome, Italy
来源：
CURRENT ONCOLOGY | 2024年 / 31卷 / 11期
关键词：
genomic profiling; targeted therapies; hypomethylating agents; venetoclax-based combinations; intensive chemotherapy; transplantation clinical trials; supportive care; quality of life; HEALTH-ORGANIZATION CLASSIFICATION; MEASURABLE RESIDUAL DISEASE; VENETOCLAX-BASED THERAPY; GILTERITINIB; AZACITIDINE; METABOLISM; CHEMOTHERAPY; NEOPLASMS; EVOLUTION; CRITERIA;
D O I：
10.3390/curroncol31110490
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Acute myeloid leukemia (AML) is a heterogeneous blood-related neoplasm that predominantly afflicts older adults with a poor prognosis due to their physical condition and the presence of medical accompanying comorbidities, adverse biological disease features, and suitability for induction intensive chemotherapy and allogenic stem cells transplantation. Recent research into the molecular and biological factors contributing to disease development and progression has led to significant advancements in treatment approaches for older patients with AML. This review article discusses the latest biological and therapeutic developments that are transforming the management of AML in older adults.
引用
收藏
页码：6632 / 6658
页数：27
相关论文
共 50 条
  • [41] Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemia
    Estey, Elihu
    Levine, Ross L.
    Lowenberg, Bob
    BLOOD, 2015, 125 (16) : 2461 - 2466
  • [42] A Functional Approach to Precision Medicine Identifies Targeted Therapies for Acute Myeloid Leukemia
    Bhatt, Shruti
    Murali, Vineeth Kumar
    Zhu, Holly
    Adamia, Sophia
    Christie, Amanda L.
    Weinstock, David M.
    Garcia, Jackie S.
    Letai, Anthony
    BLOOD, 2017, 130
  • [43] Targeted Therapies in Pediatric Acute Myeloid Leukemia-Evolving Therapeutic Landscape
    Al-Antary, Eman T. T.
    Gupte, Avanti
    Ravindranath, Yaddanapudi
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (02): : 176 - 183
  • [44] Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells
    Murphy, Lindsey A.
    Winters, Amanda C.
    BIOMEDICINES, 2023, 11 (12)
  • [45] Acute Myeloid Leukemia: A New Era of Therapies, a New Wave of Toxicities?
    Brunner, Andrew M.
    ACTA HAEMATOLOGICA, 2020, 143 (01) : 5 - 6
  • [46] Allogeneic Transplantation for Older Patients with Acute Myeloid Leukemia: The Dawn of a New Era
    Lin, Richard J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (12): : 793 - 794
  • [47] Novel drugs for older patients with acute myeloid leukemia
    G Montalban-Bravo
    G Garcia-Manero
    Leukemia, 2015, 29 : 760 - 769
  • [48] The artful management of older patients with acute myeloid leukemia
    Yang, Jay
    Schiffer, Charles A.
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (05) : 425 - 432
  • [49] Defining Acute Myeloid Leukemia Ontogeny in Older Patients
    Melody, Megan
    Kuykendall, Andrew
    Sallman, David
    Al Ali, Najla
    Zhang, Ling
    Talati, Chetasi
    Padron, Eric
    Sweet, Kendra
    Extermann, Martine
    List, Alan
    Lancet, Jeffrey
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05): : 312 - 315
  • [50] Management of older or unfit patients with acute myeloid leukemia
    Walter, R. B.
    Estey, E. H.
    LEUKEMIA, 2015, 29 (04) : 770 - 775
12345